MARDIROSSIAN, MARIO
 Distribuzione geografica
Continente #
NA - Nord America 3.406
EU - Europa 2.487
AS - Asia 2.476
SA - Sud America 335
AF - Africa 94
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 8.815
Nazione #
US - Stati Uniti d'America 3.290
IT - Italia 785
SG - Singapore 764
CN - Cina 631
PL - Polonia 550
SE - Svezia 276
BR - Brasile 270
VN - Vietnam 227
HK - Hong Kong 223
BD - Bangladesh 168
FR - Francia 141
DE - Germania 133
KR - Corea 116
GB - Regno Unito 93
FI - Finlandia 91
IN - India 85
RU - Federazione Russa 82
CA - Canada 68
NL - Olanda 66
TR - Turchia 59
UA - Ucraina 55
JP - Giappone 48
IE - Irlanda 43
MA - Marocco 43
BG - Bulgaria 40
MX - Messico 29
CH - Svizzera 22
AR - Argentina 21
IQ - Iraq 18
PK - Pakistan 18
AT - Austria 17
BE - Belgio 16
CZ - Repubblica Ceca 16
ES - Italia 16
HR - Croazia 16
ID - Indonesia 16
ZA - Sudafrica 15
TW - Taiwan 14
SA - Arabia Saudita 13
AU - Australia 10
PH - Filippine 10
SN - Senegal 10
CO - Colombia 9
MY - Malesia 9
PE - Perù 9
TH - Thailandia 9
EC - Ecuador 8
KE - Kenya 8
UZ - Uzbekistan 7
EG - Egitto 6
CR - Costa Rica 5
DK - Danimarca 5
HU - Ungheria 5
NP - Nepal 5
RO - Romania 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
GR - Grecia 4
IR - Iran 4
KZ - Kazakistan 4
VE - Venezuela 4
EU - Europa 3
IL - Israele 3
MN - Mongolia 3
NI - Nicaragua 3
PY - Paraguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BB - Barbados 2
BH - Bahrain 2
CI - Costa d'Avorio 2
CL - Cile 2
DZ - Algeria 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
JM - Giamaica 2
JO - Giordania 2
LK - Sri Lanka 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
UY - Uruguay 2
AL - Albania 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
NG - Nigeria 1
Totale 8.805
Città #
Singapore 497
Warsaw 496
Ashburn 442
Trieste 270
Fairfield 250
San Jose 244
Chandler 218
Hong Kong 213
Beijing 185
Woodbridge 153
Wilmington 115
Houston 106
Seoul 106
Ann Arbor 96
Seattle 93
Hefei 90
Ho Chi Minh City 75
Council Bluffs 73
Los Angeles 68
Cambridge 65
Princeton 64
Boardman 63
Columbus 62
Jacksonville 62
Chicago 57
Helsinki 55
New York 55
Milan 52
Hanoi 50
Lauterbourg 46
Dublin 41
Casablanca 40
Santa Clara 40
Dallas 39
Sofia 39
The Dalles 39
Redmond 37
Zgierz 35
Frankfurt am Main 34
London 31
Buffalo 30
Izmir 29
Moscow 29
Rome 27
Nuremberg 24
São Paulo 24
Tokyo 24
North Bergen 23
Orem 23
Dearborn 21
Munich 19
Ottawa 19
Nanjing 18
Phoenix 17
Bologna 16
Porto Alegre 16
Pune 16
Toronto 16
Chennai 15
Lappeenranta 15
Venice 15
Da Nang 14
Dong Ket 14
Falls Church 14
Brussels 13
Washington 13
Atlanta 12
Brooklyn 12
Des Moines 12
Paris 12
Vienna 12
Amsterdam 11
Guangzhou 11
Mexico City 11
Montreal 11
Bern 10
Dakar 10
Redondo Beach 10
Rio de Janeiro 10
San Diego 10
Shanghai 10
Taipei 10
Brno 9
Düsseldorf 9
Hangzhou 9
Miano 9
Norwalk 9
Turin 9
Austin 8
Baghdad 8
Bremen 8
Kunming 8
Manchester 8
Naples 8
Changsha 7
Denver 7
Johannesburg 7
Nairobi 7
Tashkent 7
Wroclaw 7
Totale 5.618
Nome #
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 386
Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome 374
Myticalins: A novel multigenic family of linear, cationic antimicrobial peptides from marine mussels (Mytilus spp.) 372
Proline-rich antimicrobial peptides targeting protein synthesis 364
Sviluppo e caratterizzazione di scaffold a base di polisaccaridi con proprietà antimicrobiche per la rigenerazione tissutale 294
Antibacterial Electrospun Polycaprolactone Membranes Coated with Polysaccharides and Silver Nanoparticles for Guided Bone and Tissue Regeneration 290
The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome 276
Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption 275
In vitro and in vivo evaluation of BMAP-derived peptides for the treatment of cystic fibrosis-related pulmonary infections 251
Induced expression of cathelicidins in trout (Oncorhynchus mykiss) challenged with four different bacterial pathogens 249
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria 246
Proteolytic Activity of Escherichia coli Oligopeptidase B Against Proline-Rich Antimicrobial Peptides. 232
Antibacterial rifampicin-loaded electrospun polycaprolactone membranes for ureteral regeneration 228
Methods for elucidating the mechanism of action of proline-rich and other non-lytic antimicrobial peptides 228
L-PRF Enrichment with Nanohydroxiapatite: An In Vitro Proof of Concept Study 227
Rifampicin-loaded electrospun polycaprolactone membranes: Characterization of stability, antibacterial effects and urotheliocytes proliferation 223
Search for Shorter Portions of the Proline-Rich Antimicrobial Peptide Fragment Bac5(1–25) That Retain Antimicrobial Activity by Blocking Protein Synthesis 213
Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens 208
Inner membrane proteins YgdD and SbmA are required for the complete susceptibility of escherichia coli to the proline-rich antimicrobial peptide arasin 1(1–25) 203
Antimicrobial activity of amphiphilic nanomicelles loaded with curcumin against Pseudomonas aeruginosa alone and activated by blue laser light 201
The anti-pseudomonal peptide d-bmap18 is active in cystic fibrosis sputum and displays anti-inflammatory in vitro activity 185
Cathelicidins—a rich seam of antimicrobial peptides waiting for exploitation 177
Lipopolysaccharide phosphorylation by the WaaY kinase affects the susceptibility of Escherichia coli to the human antimicrobial peptide LL-37 176
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 176
Potential novel therapeutic strategies in cystic fibrosis: antimicrobial and anti-biofilm activity of natural and designed α-helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia 166
Characterization of cetacean proline-rich antimicrobial peptides displaying activity against eskape pathogens 166
null 163
Effects of lipidation on a proline-rich antibacterial peptide 161
Designing New Hybrid Antibiotics: Proline-Rich Antimicrobial Peptides Conjugated to the Aminoglycoside Tobramycin 160
Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections 158
Proline-Rich Peptides with Improved Antimicrobial Activity against E. coli, K. pneumoniae, and A. baumannii 145
Core-shell electrospun polycaprolactone nanofibers, loaded with rifampicin and coated with silver nanoparticles, for tissue engineering applications 142
Novel synthesis of 1,2-diaza-1,3-dienes with potential biological activity from cinnamic acids and diazonium salts of anilines 142
The proline-rich myticalins from Mytilus galloprovincialis display a membrane-permeabilizing antimicrobial mode of action 139
Paenilamicins are context-specific translocation inhibitors of protein synthesis 135
Advantages of agarose on alginate for the preparation of polysaccharide/hydroxyapatite porous bone scaffolds compatible with a proline-rich antimicrobial peptide 135
Polyetheretherketone and titanium surface treatments to modify roughness and wettability – Improvement of bioactivity and antibacterial properties 134
Antimicrobial Peptide with a Bent Helix Motif Identified in Parasitic Flatworm Mesocestoides corti 125
The proline-rich antimicrobial peptide B7-005: low bacterial resistance, safe for human cells and effective in zebrafish embryo bacteraemia model 124
The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis 121
Recent applications of retro-inverso peptides 116
Natural and synthetic halogenated amino acids—structural and bioactive features in antimicrobial peptides and peptidomimetics 109
Structural and biological characterization of shortened derivatives of the cathelicidin PMAP-36 106
Unveiling the Impact of Gene Presence/Absence Variation in Driving Inter-Individual Sequence Diversity within the CRP-I Gene Family in Mytilus spp 99
Identification of genes involved in the resistance to the human antimicrobial peptide LL-37 in E. coli 88
Potential novel therapeutic strategies in cystic fibrosis: Antimicrobial and anti-biofilm activity of natural and designed -helical peptides against Staphylococcus aureus, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia 63
Testing antimicrobial peptides inhibiting protein synthesis in living E. coli and K. pneumoniae using bio-orthogonal non-canonical amino-acid tagging 31
Fragments of cathelicidins PMAP-36 and BMAP-27 and their D-enantiomers: Effects of all D substitutions on structure, protease resistance and antimicrobial properties 15
The structure of the Vibrio natriegens 70S ribosome in complex with the proline-rich antimicrobial peptide Bac5(1–17) 12
Two Shorter Variants of the Proline-Rich Antimicrobial Peptide B7-005 Scaffold Active Against Clinical Isolates of Pseudomonas aeruginosa and Staphylococcus aureus 12
Designing New Chimeric Proline-Rich Antimicrobial Peptides to Enhance Efficacy Toward the ESKAPE+E: Beyond Sequence Extension 12
Mechanistic Divergence and Differential Antibacterial Potency of the Proline-Rich Antimicrobial Peptide B7-005 Across ESKAPE + E Pathogens 10
Comparative analysis of lignin peroxidase and laccase responses to graphene-related nanomaterials 9
Totale 9.052
Categoria #
all - tutte 25.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022529 24 48 49 67 26 29 24 15 59 44 37 107
2022/2023797 73 107 51 131 67 115 20 72 63 21 41 36
2023/2024660 31 36 56 26 71 75 115 97 24 24 59 46
2024/20251.455 24 53 65 155 142 141 92 85 184 225 138 151
2025/20263.586 363 158 199 314 293 276 426 116 386 506 341 208
2026/202750 50 0 0 0 0 0 0 0 0 0 0 0
Totale 9.052